Acquiring Company
BioCryst Pharmaceuticals
Acquired Company
Astria Therapeutics
DurhamBostonBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareTherapeuticsBiopharmaDescription
BioCryst Pharmaceuticals has completed its acquisition of Astria Therapeutics to enhance its portfolio by gaining access to navenibart, a drug for hereditary angioedema. This move is part of BioCryst's strategy to expand into rare-disease treatments. The acquisition reportedly cost around $700 million. BioCryst is positioning itself as a significant player in the rare-disease market.
Quick answer
BioCryst Pharmaceuticals is acquiring Astria Therapeutics, announced August 29, 2026. BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.
- How much did BioCryst Pharmaceuticals pay for Astria Therapeutics?
- The deal value was not disclosed.
- What does BioCryst Pharmaceuticals do?
- BioCryst is focused on developing novel therapies for diseases with significant unmet needs.
- Where are BioCryst Pharmaceuticals and Astria Therapeutics based?
- BioCryst Pharmaceuticals is based in Durham, North Carolina, United States. Astria Therapeutics is based in Boston, Massachusetts, United States.
- Who are the decision-makers at BioCryst Pharmaceuticals?
- Fundz holds 5 contacts at BioCryst Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Aurinia completes acquisition of Kezar Life Sciences (August 29, 2026)
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Lakefront Biotherapeutics acquires Ouro Medicines (August 10, 2026)
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- AmyriAD acquires Recognify Life Sciences for cognition boost (October 7, 2026)
Who to call at BioCryst Pharmaceuticals, and when
When BioCryst Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day BioCryst Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioCryst Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioCryst Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioCryst Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Astria Therapeutics?
Astria Therapeutics was acquired by BioCryst Pharmaceuticals, based in Durham. The deal was reported on August 29, 2026. BioCryst is focused on developing novel therapies for diseases with significant unmet needs. BioCryst Pharmaceuticals is publicly traded (BCRX) and operates in Biotechnology.
When did BioCryst Pharmaceuticals acquire Astria Therapeutics?
BioCryst Pharmaceuticals's acquisition of Astria Therapeutics was reported on August 29, 2026. BioCryst Pharmaceuticals has completed its acquisition of Astria Therapeutics to enhance its portfolio by gaining access to navenibart, a drug for hereditary angioedema. This move is part of BioCryst's strategy to expand into rare-disease treatments. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Astria Therapeutics do?
Astria Therapeutics is a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.